MedTrace Logo

Dance Movement Therapy in the Treatment of Depressed Patients: A Randomised Controlled Trial

NCT04421651 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2020-06-09

No results posted yet for this study

Summary

This multi-centre research investigates the effects of dance movement therapy (DMT) on participants diagnosed with depression. In total, 109 persons participated in the study in various locations in Finland. All participants received treatment as usual (TAU). They were randomised into DMT + TAU (n = 52) or TAU-only (n = 57). The participants in the DMT + TAU group were offered 20 DMT sessions twice a week for 10 weeks in addition to standard care. The measurement points included pre-treatment measurement at the baseline and post-treatment measurement at the end of the intervention, which was 10 weeks after the pre-treatment measurement. The follow-up measurement was 3 months after the post-treatment measurement. The effects of the intervention were assessed with a clinical measure of depression (BDI-I) and with indicators of physical and psychological distress (CORE-OM and SCL-90). The participants in the treatment group (DMT+TAU) were compared to the participants in the control group who received TAU-only.

Conditions

Interventions

BEHAVIORAL

Dance Movement Therapy group

DMT-intervention was facilitated by a dance movement therapist and included 20 x 75 mins sessions within 10 weeks.

Sponsors & Collaborators

  • The Social Insurance Institution of Finland

    collaborator UNKNOWN

  • Finnish Dance Therapy Association

    collaborator UNKNOWN

  • University of Jyvaskyla

    lead OTHER

Principal Investigators

  • Raimo Lappalainen, Professor · University of Jyvaskyla

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-10-01
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04421651 on ClinicalTrials.gov